US Intergroup Trial of Response-Adapted Therapy for Stage III to IV Hodgkin Lymphoma Using Early Interim Fluorodeoxyglucose–Positron Emission Tomography Imaging: Southwest Oncology Group S0816

JOURNAL ARTICLE published 10 June 2016 in Journal of Clinical Oncology

Authors: Oliver W. Press | Hongli Li | Heiko Schöder | David J. Straus | Craig H. Moskowitz | Michael LeBlanc | Lisa M. Rimsza | Nancy L. Bartlett | Andrew M. Evens | Erik S. Mittra | Ann S. LaCasce | John W. Sweetenham | Paul M. Barr | Michelle A. Fanale | Michael V. Knopp | Ariela Noy | Eric D. Hsi | James R. Cook | Mary Jo Lechowicz | Randy D. Gascoyne | John P. Leonard | Brad S. Kahl | Bruce D. Cheson | Richard I. Fisher | Jonathan W. Friedberg